Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-005020

CVP, JAPAC sold 857 shares at $92.34 ($79,135)

  • CVP, JAPAC acquired 857 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-09 Exercise or conversion : show line 1 in the form 10b5-1 +857 $36.75 $31,495 18,344.74 D
2024-04-09 Sale : show line 2 in the form 10b5-1 −857 $92.34 $79,135 17,487.74 D
Open-market sales · 857 sh · avg $92.34 · $79,135

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-09 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −857 857 D
Loading xslF345X05/doc4.xml…